Targeted Drug Delivery explores a new frontier in drug research that has become a focus for developing novel medications. The work discusses a wide range of approaches for targeting small molecules as well as peptide and macromolecular drugs, from prodrugs to drug conjugates to drug carriers and devices, helping readers to stay up to date on the latest developments in the field. The following key topics are addressed: Antibody conjugates, prodrugs, and suicide gene therapeutics; Protac technology for selectively degrading target proteins; Delivery of nucleic acid drugs; Novel drug carriers, such as liposomes, vesicles, and nanoparticles; Unmet medical needs for which there is a large market potential, such as viral infections and cancer.